JPM19: Spark looks at scale, manufacturing as gene therapy matures

cafead

Administrator
Staff member
  • cafead   Jan 10, 2019 at 09:12: PM
via It was five years ago that Jeff Marrazzo, CEO of Spark Therapeutics, first stood in front of a crowd at the J.P. Morgan Healthcare Conference to outline his company's path forward. Fast forward to today, and the biotech is now a year removed from securing the first ever U.S. approval of a gene therapy for an inherited disease.

article source